Evolve Funds Launches International Equity UltraYield ETF (TSX:INTY)

Toronto, Ontario — January 15, 2026 — Leads & Copy — Evolve Funds Group Inc.’s Evolve International Equity UltraYield ETF (TSX: INTY) has launched on the Toronto Stock Exchange (TSX) following the closure of its initial unit offering, the company announced today.

The ETF, trading under the ticker symbol INTY (Hedged ETF Units), aims to provide both income and long-term capital appreciation through investments in international equity securities that offer the potential for significant option premiums.

Evolve anticipates making cash distributions on INTY twice per month, with the potential for more frequent distributions. The first distributions for INTY are outlined in the table below:

The initial distribution schedule is as follows:

Ex-Date and Record Date: January 30, 2026

Pay Date: February 6, 2026

Distribution per Unit: $0.26000

Ex-Date and Record Date: February 13, 2026

Pay Date: February 23, 2026

Distribution per Unit: $0.26000

To boost yield and mitigate risk, INTY will implement a covered call option writing program managed by Evolve. The extent of this program will be adjusted based on market volatility and other considerations.

INTY will also employ modest leverage, not exceeding approximately 33% (or 1.33x) of its net asset value (NAV), to pursue its investment goals. This leverage will be achieved through cash borrowings, derivatives, or other methods permitted by securities regulations.

Evolve Funds Group Inc. manages over $8.5 billion in assets and specializes in offering innovative ETFs to Canadian investors. Their ETFs cover index-based income strategies, long-term investment themes, and access to investment managers.

Evolve ETFs
info@evolveetfs.com
t. 416.214.4884
tf. 1.844.370.4884

MEDIA CONTACT
Keith Crone
kcrone@evolveetfs.com
416.966.8716

Evolve Funds Group Inc. is the investment fund manager and portfolio manager. Evolve International Equity UltraYield ETF (“INTY”) will be offered by Evolve Funds Group Inc., and distributed through authorized dealers.

Source: Evolve Funds Group Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.